TY - JOUR T1 - Regressing SARS-CoV-2 sewage measurements onto COVID-19 burden in the population: a proof-of-concept for quantitative environmental surveillance JF - medRxiv DO - 10.1101/2020.04.26.20073569 SP - 2020.04.26.20073569 AU - Itay Bar-Or AU - Karin Yaniv AU - Marilou Shagan AU - Eden Ozer AU - Oran Erster AU - Ella Mendelson AU - Batya Mannasse AU - Rachel Shirazi AU - Esti Kramarsky-Winter AU - Oded Nir AU - Hala Abu-Ali AU - Zeev Ronen AU - Ehud Rinott AU - Yair E. Lewis AU - Eran Friedler AU - Eden Bitkover AU - Yossi Paitan AU - Yakir Berchenko AU - Ariel Kushmaro Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/05/01/2020.04.26.20073569.abstract N2 - SARS-CoV-2 is an RNA virus, a member of the coronavirus family of respiratory viruses that includes SARS-CoV-1 and MERS. COVID-19, the clinical syndrome caused by SARSCoV-2, has evolved into a global pandemic with more than 2,900,000 people infected. It has had an acute and dramatic impact on health care systems, economies, and societies of affected countries within these few months. Widespread testing and tracing efforts are employed in many countries in order to contain and mitigate this pandemic. Recent data has indicated that fecal shedding of SARS-CoV-2 is common, and that the virus can be detected in wastewater. This indicates that wastewater monitoring is a potentially efficient tool for epidemiological surveillance of SARS-CoV-2 infection in large populations at relevant scales. Collecting raw sewage data, representing specific districts, and crosslinking this data with the number of infected people from each location, will enable us to derive and provide quantitative surveillance tools. In particular, this will provide important means to (i) estimate the extent of outbreaks and their spatial distributions, based primarily on in-sewer measurements (ii) manage the early-warning system quantitatively and efficiently (and similarly, verify disease elimination). Here we report the development of a virus concentration method using PEG or alum, providing an important a tool for detection of SARS-CoV-2 RNA in sewage and relating it to the local populations and geographic information. This will provide a proof of concept for the use of sewage associated virus data as a reliable epidemiological tool.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe would like to thank for funding from Ben Gurion University, The Corona Challenge Covid-19 (https://in.bgu.ac.il/en/corona-challenge/Pages/default.aspx) and to the wastewater treatment plants operators and IGUDAN (http://www.igudan.org.il) for help in the sampling efforts.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is included in the tables and figures ER -